Lurbinectedin in FET-Fused Tumors
Lurbinectedin in FET-Fused Tumors
Recruiting · NCT05918640 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lurbinectedin in FET-Fused Tumors | Ewing sarcoma, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, childhood malignant neoplasm, connective tissue neoplasm, desmoplastic small round cell tumor, neoplasm, osteosarcoma, sarcoma, undifferentiated (embryonal) sarcoma | Recruiting | Phase 1 / Phase 2 | 2026-09-02 | NCT05918640 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Children's Hospital of Philadelphia | 215 |
| Jazz Pharmaceuticals | 60 |
| Stand Up To Cancer | 20 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | United States | 392 |
| Children's Hospital of Philadelphia | Philadelphia | United States | 434 |
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| University of Iowa Hospitals and Clinics | Iowa City | United States | 99 |
| University of Michigan | Ann Arbor | United States | 538 |